|
GB1051723A
(enExample)
|
1962-04-27 |
|
|
|
|
US3202654A
(en)
|
1962-04-27 |
1965-08-24 |
Bristol Myers Co |
6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof
|
|
US3252970A
(en)
|
1963-02-27 |
1966-05-24 |
Ciba Geigy Corp |
Aromatization
|
|
BE631632A
(enExample)
|
1963-04-26 |
|
|
|
|
US3268558A
(en)
|
1964-11-05 |
1966-08-23 |
Ortho Pharma Corp |
1-r-2, 4-dinitropyrroles
|
|
US3458515A
(en)
|
1966-07-21 |
1969-07-29 |
American Home Prod |
Piperazine substituted pyrroles
|
|
GB1208014A
(en)
|
1967-03-23 |
1970-10-07 |
Glaxo Lab Ltd |
Cephalosporins
|
|
US3573294A
(en)
|
1968-03-14 |
1971-03-30 |
Glaxo Lab Ltd |
7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
|
|
BE790747A
(fr)
|
1971-10-30 |
1973-02-15 |
Whitefin Holding Sa |
Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
|
|
GB1476503A
(en)
|
1973-06-21 |
1977-06-16 |
Sterling Drug Inc |
1-arylamino-and 1-arylimino-pyrroles and preparation thereof
|
|
BE848465A
(fr)
|
1976-11-18 |
1977-03-16 |
|
Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
|
|
US4316900A
(en)
|
1977-10-05 |
1982-02-23 |
Ciba-Geigy Corporation |
Piperazinopyrrolobenzodiazepines
|
|
JPS57142966A
(en)
|
1981-02-27 |
1982-09-03 |
Sagami Chem Res Center |
(1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
|
|
JPS57144255A
(en)
|
1981-03-03 |
1982-09-06 |
Sagami Chem Res Center |
Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
|
|
US4761424A
(en)
|
1985-10-01 |
1988-08-02 |
Warner-Lambert Company |
Enolamides, pharmaceutical compositions and methods for treating inflammation
|
|
FR2601368B1
(fr)
|
1986-07-08 |
1989-04-07 |
Synthelabo |
Derives de nitrofuranne, leur preparation et leur application en therapeutique.
|
|
AU650953B2
(en)
|
1991-03-21 |
1994-07-07 |
Novartis Ag |
Inhaler
|
|
US5637592A
(en)
|
1994-07-12 |
1997-06-10 |
Janssen Pharmaceutica N.V. |
Acyl derivatives of azolones
|
|
US6645976B1
(en)
|
1994-07-21 |
2003-11-11 |
Eli Lilly And Company |
Indolizine SPLA2inhibitors
|
|
KR19990008109A
(ko)
|
1995-04-28 |
1999-01-25 |
나가사까 겐지로 |
1,4-이치환 피페리딘 유도체
|
|
EP0747756B1
(en)
|
1995-06-06 |
2000-05-24 |
Agfa-Gevaert N.V. |
Photographic materials
|
|
JPH09249669A
(ja)
|
1996-03-13 |
1997-09-22 |
Ono Pharmaceut Co Ltd |
縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
|
|
ES2210769T3
(es)
|
1997-06-13 |
2004-07-01 |
Cydex Inc. |
Compuesto con vida de almacenamiento prolongada que comprende ciclodextrina y medicamentos y promedicamentos que se descomponen en componentes insolubles en agua.
|
|
PT901786E
(pt)
|
1997-08-11 |
2007-08-07 |
Pfizer Prod Inc |
Disperções farmacêuticas sólidas com biodisponibilidade melhorada
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
CN100351230C
(zh)
|
1998-06-03 |
2007-11-28 |
Gpinil控股公司 |
N－杂环化合物的羧酸和羧酸电子等排物
|
|
ES2310164T3
(es)
|
1999-02-10 |
2009-01-01 |
Pfizer Products Inc. |
Dispositivo de liberacion controlada por la matriz.
|
|
BR0010279A
(pt)
|
1999-05-04 |
2002-05-14 |
Janssen Phamaceutica N V |
éteres antifúngicos
|
|
AU6438800A
(en)
|
1999-07-30 |
2001-02-19 |
Norbert Heske |
Cannula system for introducing endoscopic tools in a human or animal body
|
|
YU43702A
(sh)
|
1999-12-23 |
2004-11-25 |
Pfizer Products Inc. |
Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka
|
|
GB0011089D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (11)
|
|
US7202239B2
(en)
|
2001-04-12 |
2007-04-10 |
Wyeth |
Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
|
|
US6825201B2
(en)
|
2001-04-25 |
2004-11-30 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic amidopiperazine derivatives
|
|
DE60213802T2
(de)
|
2001-06-06 |
2007-03-29 |
Vertex Pharmaceuticals Inc., Cambridge |
Cak inhibitoren und deren verwendungen
|
|
KR100863113B1
(ko)
|
2001-06-20 |
2008-10-13 |
다이이찌 산쿄 가부시키가이샤 |
디아민 유도체
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
PL372247A1
(en)
|
2002-02-01 |
2005-07-11 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
|
|
EP1469830A2
(en)
|
2002-02-01 |
2004-10-27 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
|
|
US20040162298A1
(en)
|
2002-02-23 |
2004-08-19 |
Hsu-Tso Ho |
Method of treating HIV infection by preventing interaction of CD4 and gp120
|
|
WO2004022100A1
(en)
|
2002-08-15 |
2004-03-18 |
Yunqing Liu |
Soild nano pharmaceutical formulation and preparation method thereof
|
|
US20050032871A1
(en)
|
2002-09-03 |
2005-02-10 |
Sugen, Inc. |
Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors
|
|
JP2006520385A
(ja)
|
2003-03-13 |
2006-09-07 |
シンタ ファーマスーティカルズ コーポレイション |
縮合ピロール化合物
|
|
FR2854079B1
(fr)
|
2003-04-25 |
2007-11-30 |
Pf Medicament |
Procede de preparation de complexes moleculaires
|
|
CL2004001884A1
(es)
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
MXPA06004438A
(es)
|
2003-10-24 |
2006-06-20 |
Schering Ag |
Derivados de indolinona y su uso en el tratamiento de enfermedades como el cancer.
|
|
EP1753402B1
(en)
|
2004-05-28 |
2008-10-01 |
Pfizer Products Incorporated |
Pharmaceutical compositions with enhanced performance comprising a hpmca polymer
|
|
US20060058286A1
(en)
|
2004-09-16 |
2006-03-16 |
Mark Krystal |
Methods of treating HIV infection
|
|
EP1844078B1
(en)
|
2005-02-03 |
2016-09-28 |
Bend Research, Inc |
Pharmaceutical compositions with enhanced performance
|
|
AU2006230364B2
(en)
|
2005-03-31 |
2012-09-13 |
Janssen Pharmaceutica N.V. |
Bicyclic pyrazole compounds as antibacterial agents
|
|
AR053713A1
(es)
|
2005-04-20 |
2007-05-16 |
Xenon Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos como agentes terapeuticos
|
|
AU2006248812B2
(en)
|
2005-05-18 |
2012-02-16 |
F2G Ltd |
Antifungal agents
|
|
JP2009501721A
(ja)
|
2005-07-12 |
2009-01-22 |
アカディア ファーマシューティカルズ インコーポレイテッド |
レチノイン酸受容体における活性を伴う化合物
|
|
WO2007015866A2
(en)
|
2005-07-20 |
2007-02-08 |
Kalypsys, Inc. |
Inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
WO2007109605A2
(en)
|
2006-03-20 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
|
US20080118500A1
(en)
|
2006-11-16 |
2008-05-22 |
Taiwan Liposome Company |
Sustained releasing composition via local injection for treating eye diseases
|
|
GB0623209D0
(en)
|
2006-11-21 |
2007-01-03 |
F2G Ltd |
Antifungal agents
|
|
JP5508859B2
(ja)
|
2007-01-26 |
2014-06-04 |
アイエスピー インヴェストメンツ インコーポレイテッド |
噴霧乾燥製品を製造するための調剤処理方法
|
|
CN101260086B
(zh)
|
2007-03-06 |
2011-08-10 |
中国科学院上海药物研究所 |
蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
|
|
GB0710121D0
(en)
|
2007-05-25 |
2007-07-04 |
F2G Ltd |
Antifungal agents
|
|
US20100215747A1
(en)
|
2007-07-13 |
2010-08-26 |
Corey Jay Bloom |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
JP5657524B2
(ja)
|
2008-04-24 |
2015-01-21 |
エフツージー リミテッド |
ピロール抗真菌剤
|
|
GB0809773D0
(en)
|
2008-05-29 |
2008-07-09 |
F2G Ltd |
Antifungal combination therapy
|
|
US20100093872A1
(en)
|
2008-10-15 |
2010-04-15 |
Erimos Pharmaceuticals Llc |
Stable aqueous formulations of water insoluble or poorly soluble drugs
|
|
KR20120005460A
(ko)
|
2009-04-28 |
2012-01-16 |
베링거 인겔하임 인터내셔날 게엠베하 |
Ｐｋｃ-세타 억제제를 사용하는 면역학적 장애의 생체외 치료
|
|
WO2011159626A1
(en)
|
2010-06-14 |
2011-12-22 |
Bend Research, Inc. |
Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
|
|
WO2012031129A2
(en)
|
2010-09-03 |
2012-03-08 |
Bend Research, Inc. |
Spray-drying apparatus and methods of using the same
|
|
WO2012060448A1
(ja)
|
2010-11-05 |
2012-05-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗真菌剤としての併用医薬組成物
|
|
CN102805733B
(zh)
|
2011-06-01 |
2016-03-09 |
日东电工株式会社 |
颗粒制剂及其制造方法
|
|
ES2784629T3
(es)
|
2011-11-29 |
2020-09-29 |
Jurox Pty Ltd |
Composiciones farmacéuticas inyectables estables que comprenden 2-hidroxipropil-beta-ciclodextrina y alfaxalona
|
|
US9320799B2
(en)
|
2012-04-11 |
2016-04-26 |
Dow Global Technologies Llc |
Esterified cellulose ethers having a specific substituent distribution
|
|
BR112015002055A2
(pt)
|
2012-08-24 |
2017-07-04 |
Dow Global Technologies Llc |
acetato succinato de hidroxialquil metil celulose, composição, dispersão sólida, processo para produzir uma dispersão sólida, forma de dosagem e cápsula de envoltório
|
|
EP2888289B1
(en)
|
2012-08-24 |
2019-08-07 |
Dow Global Technologies LLC |
Partially cross-linked esterified cellulose ethers
|
|
NZ708272A
(en)
|
2013-01-22 |
2020-07-31 |
Hoffmann La Roche |
Pharmaceutical composition with improved bioavailability
|
|
WO2015007759A1
(en)
|
2013-07-19 |
2015-01-22 |
Boehringer Ingelheim Vetmedica Gmbh |
Etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
|
AU2014292086B2
(en)
|
2013-07-19 |
2019-08-08 |
Boehringer Ingelheim Vetmedica Gmbh |
Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
|
CA2928772A1
(en)
|
2013-12-05 |
2015-06-11 |
Alrise Biosystems Gmbh |
Process for the production of drug formulations for oral administration
|
|
PT107568B
(pt)
|
2014-03-31 |
2018-11-05 |
Hovione Farm S A |
Processo de secagem por atomização para a produção de pós com propriedades melhoradas.
|
|
PL3221308T3
(pl)
*
|
2014-11-21 |
2019-03-29 |
F2G Limited |
Środki przeciwgrzybicze
|
|
GB201609222D0
(en)
*
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|